Autonomic Nervous System Drugs Practice Questions

Q: Which of the following drugs possesses similar cycloplegic action and is a more potent mydriatic than atropine?

Hyoscine. **Explanation:** The correct answer is **Hyoscine (Scopolamine)**. **Why Hyoscine is the correct answer:** Hyoscine is a belladonna alkaloid that acts as a competitive antagonist at muscarinic receptors. In terms of ocular potency, it is significantly more potent than atropine on a weight-for-weight basis. While it produces a **similar degree of cycloplegia** (paralysis of the ciliary muscle), it is a **more potent mydriatic** (pupillary dilator) than atropine. Its duration of action (3–7 days) is shorter than that of atropine (7–10 days), making it a useful alternative when a potent but slightly shorter-acting cycloplegic is required. **Analysis of Incorrect Options:** * **Tropicamide:** This is the shortest-acting mydriatic (duration 4–6 hours). While it is excellent for fundus examination, its cycloplegic action is much weaker and shorter than atropine. * **Homatropine:** A semi-synthetic derivative that is 10 times less potent than atropine. It has a shorter duration of action (1–3 days) and is primarily used in the treatment of anterior uveitis to prevent synechiae without the prolonged blurriness of atropine. **High-Yield Clinical Pearls for NEET-PG:** * **Potency Order:** Hyoscine > Atropine > Homatropine. * **Duration of Action (Cycloplegia):** Atropine (7–10 days) > Hyoscine (3–7 days) > Homatropine (1–3 days) > Cyclopentolate (24 hours) > Tropicamide (6 hours). * **Drug of Choice:** Atropine is the drug of choice for refraction in children <5 years (due to strong accommodation), while Homatropine/Cyclopentolate is preferred for older children. * **Side Effect:** Systemic absorption of atropine in children can lead to "Atropine flushing," fever, and tachycardia.

Q: Which beta-blocker possesses an additional alpha-blocking property?

Labetalol. ### Explanation **Correct Option: D. Labetalol** Labetalol is a **mixed antagonist** that blocks both $\beta$ (non-selective $\beta_1$ and $\beta_2$) and $\alpha_1$ receptors. The ratio of $\beta$ to $\alpha$ blockade is approximately 3:1 for oral administration and 7:1 for intravenous use. By blocking $\alpha_1$ receptors, it induces peripheral vasodilation, while its $\beta$-blocking property prevents the reflex tachycardia typically seen with pure vasodilators. This dual action makes it highly effective in managing hypertensive emergencies. **Analysis of Incorrect Options:** * **A. Propranolol:** A prototype **non-selective $\beta$-blocker** ($\beta_1$ and $\beta_2$). It lacks $\alpha$-blocking activity and can actually cause initial peripheral vasoconstriction due to unopposed $\alpha$ activity. * **B. Timolol:** A **non-selective $\beta$-blocker** primarily used in the management of glaucoma by reducing aqueous humor production. It has no $\alpha$-blocking properties. * **C. Metoprolol:** A **cardioselective ($\beta_1$) blocker**. It does not block $\alpha$ receptors and is preferred in patients with bronchial asthma or diabetes where $\beta_2$ blockade should be avoided. **High-Yield Clinical Pearls for NEET-PG:** * **Carvedilol** is the other major mixed $\alpha$ and $\beta$ blocker; it also possesses antioxidant properties and is a mainstay in Chronic Heart Failure (CHF) management. * **Labetalol** is the **drug of choice for Pregnancy-Induced Hypertension (PIH)** and Eclampsia. * **Nebivolol** is a highly selective $\beta_1$ blocker that also causes vasodilation, but via **Nitric Oxide (NO) release**, not $\alpha$-blockade. * **Esmolol** is the shortest-acting $\beta$-blocker (half-life ~9 mins) due to metabolism by RBC esterases.

Q: Which of the following drugs binds only with the anionic site of cholinesterase?

Edrophonium. ### Explanation The enzyme **Acetylcholinesterase (AChE)** possesses two primary binding domains: the **anionic site** (which attracts the positive quaternary ammonium group of acetylcholine) and the **esteratic site** (where the actual hydrolysis occurs). #### Why Edrophonium is Correct **Edrophonium** is a quaternary ammonium compound that binds **reversibly and non-covalently** only to the **anionic site** of the enzyme via electrostatic attraction. Because it does not form a covalent bond with the esteratic site, its binding is very weak and short-lived. This explains its rapid onset and very short duration of action (5–15 minutes). #### Why Other Options are Incorrect * **Physostigmine, Neostigmine, and Pyridostigmine** are **Carbamates**. These drugs are "substrate substitutes." They bind to **both the anionic and the esteratic sites**. * Unlike Edrophonium, they covalently transfer a carbamoyl group to the esteratic site (carbamoylation). This bond is much more stable than the simple ionic attraction of Edrophonium, leading to a longer duration of action (0.5 to 6 hours). * **Physostigmine** is a tertiary amine (crosses BBB), while **Neostigmine** and **Pyridostigmine** are quaternary amines (do not cross BBB). #### NEET-PG High-Yield Pearls * **Tensilon Test:** Edrophonium was historically used to diagnose Myasthenia Gravis (MG) due to its rapid action. A brief improvement in muscle strength indicates a positive test. * **Differentiation:** It is also used to differentiate between a **Myasthenic crisis** (improvement with Edrophonium) and a **Cholinergic crisis** (worsening with Edrophonium). * **Drug of Choice:** Pyridostigmine is the DOC for the long-term oral treatment of Myasthenia Gravis. * **Antidote:** Physostigmine is the specific antidote for Atropine (anticholinergic) poisoning.

Q: Atracurium is primarily eliminated by which mechanism?

Nonenzymatic degradation. **Explanation:** **Atracurium** is a benzylisoquinolinium neuromuscular blocking agent unique for its organ-independent elimination. The correct answer is **Nonenzymatic degradation**, specifically a process known as **Hofmann elimination**. 1. **Why Option C is Correct:** Atracurium undergoes spontaneous molecular breakdown at physiological pH and temperature (Hofmann elimination). It is also metabolized by **ester hydrolysis** via non-specific plasma esterases. Because it does not rely on organ function for clearance, it is the drug of choice for patients with **renal or hepatic failure**. 2. **Why Other Options are Incorrect:** * **Option A & B:** While most muscle relaxants (like Vecuronium or Pancuronium) depend on the kidneys or liver for excretion, Atracurium’s primary pathway bypasses these organs. Impairment in renal or hepatic function does not significantly prolong its duration of action. * **Option D:** Since the primary and clinically significant route is nonenzymatic, "All of the above" is incorrect. **High-Yield Clinical Pearls for NEET-PG:** * **Laudanosine Toxicity:** Hofmann elimination produces a metabolite called *Laudanosine*. In high concentrations (prolonged infusions), it can cross the blood-brain barrier and act as a **CNS stimulant**, potentially causing **seizures**. * **Cisatracurium:** An isomer of atracurium that is more potent, produces less laudanosine, and does not cause **histamine release** (unlike atracurium, which can cause flushing and hypotension). * **Temperature/pH Sensitivity:** Since Hofmann elimination is spontaneous, the rate of degradation increases with hyperthermia/alkalosis and decreases with hypothermia/acidosis.

Q: A 30-year-old theatre actress developed facial wrinkles. The treating physician advised local injections of a drug indicated in cervical dystonia, spastic disorders like cerebral palsy, and prophylaxis of migraine. The physician warned of potential side effects including dry mouth and blurred vision. The actress identified the drug's site of action as depicted in the accompanying figure. Which of the following drugs is being described?

Botulinum toxin. ***Botulinum toxin*** - Cleaves **SNARE proteins** (SNAP-25, syntaxin, synaptobrevin) at the **presynaptic terminal**, blocking **acetylcholine exocytosis** from nerve endings. - Used for **cosmetic wrinkles**, **cervical dystonia**, **cerebral palsy spasticity**, and **migraine prophylaxis**; causes **anticholinergic effects** like dry mouth and blurred vision. *Hemicholinium* - Blocks **choline reuptake** at the presynaptic terminal, depleting acetylcholine synthesis over time. - Not used clinically for cosmetic purposes or the mentioned conditions; primarily a research tool. *Vesamicol* - Inhibits **vesicular acetylcholine transporter (VAChT)**, preventing acetylcholine packaging into synaptic vesicles. - Research compound with no clinical applications for wrinkles, dystonia, or migraine prophylaxis. *Physostigmine* - **Acetylcholinesterase inhibitor** that acts in the **synaptic cleft**, increasing acetylcholine availability. - Used as antidote for **anticholinergic poisoning**; would worsen rather than treat spastic disorders and dystonia.

Q: A 68-year-old male with hypertension presents for annual examination. On review of systems, he reports urinary hesitancy and nocturia. His examination reveals a nontender but enlarged prostate without nodules. His blood pressure logs and clinic readings show average values of 150/80 mm Hg. Which medication offer treatment of hypertension and prostatic symptoms?

Terazosin. **Explanation:** The patient presents with classic symptoms of **Benign Prostatic Hyperplasia (BPH)** (urinary hesitancy, nocturia, enlarged smooth prostate) and **Stage 2 Hypertension**. The goal is to identify a medication that addresses both conditions simultaneously. **Why Terazosin is correct:** Terazosin is a **selective alpha-1 adrenergic receptor antagonist**. 1. **In BPH:** It relaxes the smooth muscle in the bladder neck and prostatic capsule, reducing dynamic urethral obstruction and improving urinary flow. 2. **In Hypertension:** It causes peripheral vasodilation by blocking alpha-1 receptors on vascular smooth muscle, thereby lowering blood pressure. While no longer first-line for isolated hypertension, alpha-blockers (Terazosin, Doxazosin) are the drug of choice for patients with comorbid BPH. **Why other options are incorrect:** * **A. Aliskiren:** A direct renin inhibitor. While it treats hypertension, it has no effect on the smooth muscle of the prostate. * **B. Propranolol:** A non-selective beta-blocker. It is used for tremors, portal hypertension, or migraine prophylaxis, but it does not improve BPH symptoms and may even worsen them by allowing unopposed alpha-constriction. * **C. Furosemide:** A loop diuretic. It treats fluid overload but would **exacerbate nocturia** and urinary frequency in a patient with BPH. **NEET-PG High-Yield Pearls:** * **First-dose phenomenon:** Alpha-blockers can cause significant orthostatic hypotension; patients should take the first dose at bedtime. * **Tamsulosin vs. Terazosin:** Tamsulosin is uro-selective (Alpha-1A), meaning it improves BPH symptoms with minimal effect on blood pressure. For a patient with *both* BPH and HTN, non-selective alpha-1 blockers like **Terazosin or Doxazosin** are preferred. * **IFIS:** Alpha-blockers are associated with **Intraoperative Floppy Iris Syndrome** during cataract surgery.

Q: Which is a depolarizing skeletal muscle relaxant?

Suxamethonium. ### Explanation **Correct Answer: A. Suxamethonium** **Mechanism of Action:** Suxamethonium (Succinylcholine) is the **only** depolarizing neuromuscular blocking agent (NMBA) used clinically. It acts as an agonist at the nicotinic acetylcholine receptors (nAChR) at the motor endplate. Unlike acetylcholine, it is not metabolized by acetylcholinesterase, leading to prolonged depolarization. This results in initial muscle twitching (**fasciculations**) followed by flaccid paralysis because the post-junctional membrane becomes unresponsive to subsequent stimuli (Phase I block). **Analysis of Incorrect Options:** Options B, C, and D are all **Non-depolarizing NMBAs**. They act as competitive antagonists at the nAChR, preventing acetylcholine from binding. * **B. Mivacurium:** A short-acting benzylisoquinolone metabolized by plasma cholinesterase. * **C. Pancuronium:** A long-acting aminosteroid known for causing tachycardia (vagolytic effect). * **D. Vecuronium:** An intermediate-acting aminosteroid with minimal cardiovascular side effects. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** Suxamethonium is rapidly hydrolyzed by **Pseudocholinesterase** (Plasma cholinesterase). A deficiency in this enzyme leads to prolonged apnea. * **Onset/Duration:** It has the fastest onset (30–60 seconds) and shortest duration (5–10 minutes), making it the drug of choice for **Rapid Sequence Induction (RSI)**. * **Key Side Effects:** Hyperkalemia (avoid in burns, trauma, and denervation injuries), muscle soreness, increased intraocular/intragastric pressure, and it is a potent trigger for **Malignant Hyperthermia**. * **Antidote:** There is no pharmacological reversal for a Phase I block; however, Sugammadex can reverse aminosteroids like Vecuronium and Rocuronium.

Q: Which of the following is a long-acting non-depolarizing competitive blocker?

Doxacurium. **Explanation:** Neuromuscular blockers (NMBs) are classified based on their mechanism of action and duration of effect. Non-depolarizing blockers act as competitive antagonists at the nicotinic receptors ($N_m$) of the neuromuscular junction. **1. Why Doxacurium is correct:** Doxacurium belongs to the **Benzylisoquinolinium** class. It is characterized as a **long-acting** agent with a duration of action typically exceeding 60–90 minutes. It is highly potent and lacks significant cardiovascular side effects (no histamine release), making it suitable for long surgical procedures. **2. Why the other options are incorrect:** * **Rocuronium:** This is an **intermediate-acting** steroid-based NMB. It is notable for its rapid onset of action, making it the preferred alternative to Succinylcholine for Rapid Sequence Induction (RSI). * **Mivacurium:** This is a **short-acting** benzylisoquinolinium. It is unique because it is metabolized by plasma cholinesterase (like Succinylcholine), leading to a brief duration of action (approx. 15–20 mins). * **Atracurium:** This is an **intermediate-acting** agent. It is famous for undergoing **Hofmann Elimination** (spontaneous non-enzymatic degradation), making it safe for patients with liver or kidney failure. **High-Yield Clinical Pearls for NEET-PG:** * **Longest acting NMB:** Pancuronium or Doxacurium. * **Shortest acting Non-depolarizing NMB:** Mivacurium. * **Drug of choice in Renal/Hepatic failure:** Atracurium or Cisatracurium (due to Hofmann elimination). * **Laudanosine Toxicity:** A metabolite of Atracurium that can cross the BBB and cause seizures. * **Reversal Agent:** Sugammadex is specifically used to reverse "onium" drugs (Rocuronium > Vecuronium).

Question 1

Which of the following drugs possesses similar cycloplegic action and is a more potent mydriatic than atropine?

Accepted Answer

Hyoscine

Answer

Tropicamide

Answer

Homatropine

Answer

All of the above

Question 2

Which beta-blocker possesses an additional alpha-blocking property?

Accepted Answer

Labetalol

Answer

Propranolol

Answer

Timolol

Answer

Metoprolol

Question 3

Which of the following drugs binds only with the anionic site of cholinesterase?

Accepted Answer

Edrophonium

Answer

Physostigmine

Answer

Neostigmine

Answer

Pyridostigmine

Question 4

Atracurium is primarily eliminated by which mechanism?

Accepted Answer

Nonenzymatic degradation

Answer

Renal excretion

Answer

Hepatic elimination

Answer

All of the above

Question 5

A 30-year-old theatre actress developed facial wrinkles. The treating physician advised local injections of a drug indicated in cervical dystonia, spastic disorders like cerebral palsy, and prophylaxis of migraine. The physician warned of potential side effects including dry mouth and blurred vision. The actress identified the drug's site of action as depicted in the accompanying figure. Which of the following drugs is being described?

Accepted Answer

Botulinum toxin

Answer

Hemicholinium

Answer

Vesamicol

Answer

Physostigmine

Question 6

Propranolol is contraindicated in diabetes mellitus because it:

Accepted Answer

Masks the hypoglycemic symptoms

Answer

Causes hyperglycemia

Answer

Causes seizures

Answer

Causes hypotension

Question 7

A 68-year-old male with hypertension presents for annual examination. On review of systems, he reports urinary hesitancy and nocturia. His examination reveals a nontender but enlarged prostate without nodules. His blood pressure logs and clinic readings show average values of 150/80 mm Hg. Which medication offer treatment of hypertension and prostatic symptoms?

Accepted Answer

Terazosin

Answer

Aliskiren

Answer

Propranolol

Answer

Furosemide

Question 8

Which is a depolarizing skeletal muscle relaxant?

Accepted Answer

Suxamethonium

Answer

Mivacurium

Answer

Pancuronium

Answer

Vecuronium

Question 9

In atropine instillation, all are seen except:

Accepted Answer

Increased water content to tear

Answer

Dilated pupil

Answer

Paralysis of accommodation

Answer

Decreased water content to tear

Question 10

Which of the following is a long-acting non-depolarizing competitive blocker?

Accepted Answer

Doxacurium

Answer

Rocuronium

Answer

Mivacurium

Answer

Atracurium

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?